We speculate that Fetuin-A could modulate the effect of age by exhibiting elevated values, strongly associated with NAFLD, in CAD, which is more prone to lipid core plaques, and decreased values, weakly associated with NAFLD, in PAD, more commonly characterized by fibro-calcific plaques. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.